Literature DB >> 18625828

Bisphosphonate-associated osteonecrosis of the jaw.

Aliya Khan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18625828      PMCID： PMC2464788     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  26 in total

1.  Oral ulceration with bone sequestration.

Authors:  C S Farah; N W Savage
Journal:  Aust Dent J       Date:  2003-03       Impact factor: 2.291

2.  Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid.

Authors:  Meletios A Dimopoulos; Efstathios Kastritis; Athanasios Anagnostopoulos; Ioannis Melakopoulos; Dimitra Gika; Lia A Moulopoulos; Christina Bamia; Evangelos Terpos; Konstantinos Tsionos; Aristotelis Bamias
Journal:  Haematologica       Date:  2006-06-01       Impact factor: 9.941

3.  Diabetes and the risk of osteonecrosis of the jaw.

Authors:  Murray J Favus
Journal:  J Clin Endocrinol Metab       Date:  2007-03       Impact factor: 5.958

4.  Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.

Authors:  I Dimitrakopoulos; C Magopoulos; D Karakasis
Journal:  Int J Oral Maxillofac Surg       Date:  2006-05-09       Impact factor: 2.789

Review 5.  The use of bisphosphonates in men with hormone-refractory prostate cancer: a systematic review of randomized trials.

Authors:  Scott Berry; Tricia Waldron; Eric Winquist; Himu Lukka
Journal:  Can J Urol       Date:  2006-08       Impact factor: 1.344

6.  Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.

Authors:  Tony Mavrokokki; Andrew Cheng; Brien Stein; Alastair Goss
Journal:  J Oral Maxillofac Surg       Date:  2007-03       Impact factor: 1.895

7.  American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma.

Authors:  James R Berenson; Bruce E Hillner; Robert A Kyle; Ken Anderson; Allan Lipton; Gary C Yee; J Sybil Biermann
Journal:  J Clin Oncol       Date:  2002-09-01       Impact factor: 44.544

8.  Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research.

Authors:  Sundeep Khosla; David Burr; Jane Cauley; David W Dempster; Peter R Ebeling; Dieter Felsenberg; Robert F Gagel; Vincente Gilsanz; Theresa Guise; Sreenivas Koka; Laurie K McCauley; Joan McGowan; Marc D McKee; Suresh Mohla; David G Pendrys; Lawrence G Raisz; Salvatore L Ruggiero; David M Shafer; Lillian Shum; Stuart L Silverman; Catherine H Van Poznak; Nelson Watts; Sook-Bin Woo; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2007-10       Impact factor: 6.741

Review 9.  A review of bisphosphonate-associated osteonecrosis of the jaws and its management.

Authors:  David K Lam; George K B Sándor; Howard I Holmes; A Wayne Evans; Cameron M L Clokie
Journal:  J Can Dent Assoc       Date:  2007-06       Impact factor: 1.316

10.  American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma.

Authors:  Robert A Kyle; Gary C Yee; Mark R Somerfield; Patrick J Flynn; Susan Halabi; Sundar Jagannath; Robert Z Orlowski; David G Roodman; Patricia Twilde; Kenneth Anderson
Journal:  J Clin Oncol       Date:  2007-05-21       Impact factor: 44.544
View more
  6 in total

Review 1.  Ocular side effects of bisphosphonates: A case report and literature review.

Authors:  Meredith McKague; Derek Jorgenson; Kelly A Buxton
Journal:  Can Fam Physician       Date:  2010-10       Impact factor: 3.275

2.  Osteoporosis: Staying strong.

Authors:  Carolyn Brown
Journal:  Nature       Date:  2017-10-04       Impact factor: 49.962

Review 3.  Novel advances in the treatment of osteoporosis.

Authors:  Christopher K Y Chan; Alice Mason; Cyrus Cooper; Elaine Dennison
Journal:  Br Med Bull       Date:  2016-08-24       Impact factor: 4.291

4.  Use of paclitaxel carried in lipid core nanoparticles in patients with late-stage solid cancers with bone metastases: Lack of toxicity and therapeutic benefits.

Authors:  Carolina G Vital; Raul C Maranhão; Fatima R Freitas; Brigitte M Van Eyll; Silvia R Graziani
Journal:  J Bone Oncol       Date:  2022-04-20       Impact factor: 4.491

Review 5.  Impact of 3D cell culture on bone regeneration potential of mesenchymal stromal cells.

Authors:  Mesude Bicer; Graeme S Cottrell; Darius Widera
Journal:  Stem Cell Res Ther       Date:  2021-01-07       Impact factor: 6.832

Review 6.  Bisphosphonate-related osteonecrosis of the jaw: historical, ethical, and legal issues associated with prescribing.

Authors:  Beth Faiman; Aiswarya Lekshmi Pillai Chandran Pillai; Ana Gabriela Benghiac
Journal:  J Adv Pract Oncol       Date:  2013-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.